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Abstract
Background: This paper describes the study protocol of a hybrid type I randomized controlled trial that evaluates
the effectiveness and cost-effectiveness of implementing Empowering African-American Women on the Road to
Health (E-WORTH), an Afrocentric, group-based, computerized human immunodeficiency virus (HIV)/sexually
transmitted infection (STI) prevention intervention for controlled substance-using black women in community
corrections settings in New York City.
Methods/design: We provide an overview of E-WORTH’s hybrid type I design, which is guided by the Consolidated
Framework for Implementation Research (CFIR). E-WORTH combines HIV/STI and intimate partner violence (IPV)
prevention components and tests the comparative effectiveness of E-WORTH and streamlined HIV testing versus
streamlined HIV testing alone in decreasing biologically confirmed HIV and STI incidence, sexual risk, and IPV, as
well as in improving access to HIV and STI prevention services and care.
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Discussion: This paper provides an overview of E-WORTH’s intervention protocol and serves as a framework for
using hybrid type I designs, guided by the CFIR conceptual framework, to evaluate HIV/STI and IPV prevention
interventions in community corrections settings. We discuss how E-WORTH’s hybrid type I design advances
implementation science through its effectiveness and cost-effectiveness aims as well as through a mixed-methods
study that evaluates multilevel theory-driven factors (structural, organizational, staffing, and client) guided by the
CFIR that influences the implementation of E-WORTH in a criminal justice setting. This study also addresses the
novel challenges and opportunities of implementing an intervention that targets specific racial subgroup(s) in a
community corrections setting that services all populations, implementing a group-based intervention with
technological components in such settings, and employing community-based participatory research strategies to
guide recruitment and retention efforts.
Trial registration: ClinicalTrials.gov, NCT02391233. Registered on 17 March 2015.
Background
Human immunodeficiency virus (HIV) and other sexually
transmitted infections (STIs) disproportionately affect
criminal justice-involved black women in the United
States who use drugs [1–6]. Despite more than 30 years of
targeted prevention research and public health interven-
tions, rates of HIV infection and STIs among black
women remain disturbingly high when compared with
women of other races and ethnicities [7–9]. Black women
account for 60% of all new HIV infections among women,
although they represent approximately 13% of the general
female population [7, 8]. Specifically, when compared with
white women, black women have 5.4 times the rate of
chlamydia, 8.8 times the rates of primary and secondary
syphilis, and 9.7 times the rate of gonorrhea [7].
Black women are also highly represented in multiple
sectors of the criminal justice system [10–13]. They are
more than twice as likely to become imprisoned as white
women, and drug-related crimes remain a leading cause
of arrest and incarceration [10–12, 14]. However, the vast
majority of criminal justice-involved women are not cur-
rently incarcerated. Of the 1.2 million women convicted
of a crime, only 15% are incarcerated; the remaining 85%,
or approximately 1 million women each year, are
sentenced to some form of community corrections
(probation, parole, drug treatment court, alternative to
incarceration) [13, 15, 16]. When compared with
justice-involved women of other ethnicities and racial
backgrounds, black women serving sentences in the com-
munity are more likely to engage in a variety of risky sex-
ual behaviors, including having unprotected sex with
paying partners, using illicit substances before and during
sexual encounters, and trading sex for drugs [17–21].
In light of the aforementioned considerations, the im-
portance of providing testing and HIV/STI prevention
services to justice-involved populations in community
corrections settings has gained attention in the past dec-
ade [2, 4, 15, 16, 22–24]. Increasing the number and
quality of health services in these settings has been posi-
tively linked to a greater use of health care and a reduc-
tion in future justice system involvement [24–27].
Furthermore, although few in number, HIV/STI preven-
tion interventions delivered in community justice set-
tings have been found to increase treatment adherence,
HIV and STI testing, and protected sex acts and to de-
crease risky sexual behaviors [3, 28–33]. A randomized
controlled trial conducted with 1263 probationers and
parolees found that participants who were assigned the
option to receive on-site rapid HIV testing at probation
offices were significantly more likely to get tested than
participants assigned to an off-site community HIV test-
ing site, owing to barriers associated with travel, court
mandates, and stigma [31]. A 2009 randomized trial
examining the efficacy of brief negotiation interviewing
when compared with usual educational activities (N = 212)
found that participants randomized to the brief negoti-
ation interviewing treatment arm had significantly higher
rates of HIV testing than those assigned to the control
condition [28]. In addition, participants in the interven-
tion arm were more likely to contemplate changing
risky behavior. In a multisite randomized control trial,
Nydegger and colleagues administered a 1-hour HIV
educational group session to increase intention to use
condoms among nonviolent drug offenders participat-
ing in mandatory drug diversion programs in Southern
California (N = 143) [32]. Participants assigned to the
experimental arm reported stronger implementation
intentions to use condoms than those in the control
arm (p < 0.001).
Meyer and colleagues conducted an exhaustive review
of the literature published in the United States to iden-
tify optimal strategies for delivering evidence-based
HIV interventions in criminal justice settings or to
justice-involved populations [24]. Importantly, the re-
searchers found that a mere 16% of all interventions
identified (7 of a total of 42) were delivered in
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community corrections settings. Only one of the seven,
the one from which the intervention in the present
study was adapted (Women on the Road to Health
[WORTH]), was explicitly designed for women [24].
Substantial research has established the effectiveness of
HIV/STI prevention interventions that are specifically
tailored to black persons, women, and black women
through the use of culturally congruent and
gender-congruent themes and relevant peer group facil-
itators [34–36]. To date, however, despite continuing
disproportionately high rates of STIs, rates of criminal
justice involvement, and illicit substance use [18, 20,
37], there are no prevention interventions tailored to
the needs of drug-using black women involved in the
criminal justice system and none that have been tested
in hybrid type I effectiveness trials.
Intertwined with the HIV/STI epidemic among
substance-using black women who are involved in the
criminal justice system is the co-occurring epidemic of
intimate partner violence (IPV) [38–40]. Approximately
70% of substance-using black women in the 2009 trial of
the multimedia WORTH intervention reported experi-
encing physical, sexual, and/or injurious IPV in their
lifetime [21]. Abundant research has found that experi-
encing IPV is strongly associated with engaging in un-
protected sex, having multiple sexual partners, testing
positive for HIV/STIs, and failure to access and adhere
to HIV treatment [41–45]. The multimedia WORTH
intervention was found to be efficacious in reducing
physical, sexual, and injurious IPV at the 12-month
follow-up compared with the Wellness Promotion con-
trol group [21].
E-WORTH (Empowering African-American Women
on the Road to Health) fills these gaps. (Although the
term African-African is used in the title of the interven-
tion, E-WORTH is designed for all women who
self-identify as black.) E-WORTH extends the reach of
HIV/STI prevention efforts and the original scope of
WORTH by targeting substance-using black women via
the venue of community corrections. Adapted from the
WORTH intervention, E-WORTH is imbued with the
Afrocentric themes of risk and resiliency and is designed
to reach the large and highly vulnerable number of
justice-involved black women who remain at very high
risk for HIV/STIs and IPV. E-WORTH, and the 2009
Multimedia WORTH intervention, includes a comput-
erized self-paced IPV screening, brief intervention,
and referral to treatment tool using the Screening,
Brief Intervention, and Referral to Treatment tool
(SBIRT) [3, 21].
This paper describes a randomized controlled hybrid
effectiveness-implementation type I trial that blends ef-
fectiveness and implementation science, as well as the
trial methodology used to evaluate the effectiveness and
cost-effectiveness of delivering E-WORTH [46]. The aim
of the study is to evaluate the effectiveness of delivering
E-WORTH in a real-world setting and combining
E-WORTH and streamlined HIV testing versus stream-
lined HIV testing alone as a comparison condition to re-
duce HIV/STIs among substance-using black women in
community corrections settings. The streamlined HIV
testing component used in both intervention arms is a
very brief HIV information intervention provided with
rapid HIV testing. Streamlined testing has been found to
be as effective in increasing HIV testing rates and lower-
ing behavioral risks with at-risk populations as more in-
tensive HIV testing and counseling [47, 48].
We provide an overview of the study protocol and
discuss the innovative approaches used in evaluating
the effectiveness and cost-effectiveness aims. We de-
scribe the challenges and opportunities of using of
technology to implement E-WORTH in community
corrections settings. We also provide an overview of
our use of community-based participatory research
(CBPR) strategies to solicit feedback regarding the
adaptation and implementation of the study from key
community partners, including former study partici-
pants who meet study criteria; criminal justice advo-
cates; service providers from harm reduction, substance
abuse treatment, and criminal justice organizations;
and government representatives from community cor-
rections and the New York City Department of Health.
E-WORTH employs mixed methods to identify the
multilevel structural, community, organizational, staff-
ing, and client factors that influence the delivery of
E-WORTH in community corrections settings. In
addition, we highlight the use of Social Cognitive The-
ory [49, 50] and Empowerment Theory [51] to guide
the intervention. We also review the use of the Consoli-
dated Framework for Implementation Research (CFIR)
[52] conceptual framework to guide the adoption, im-
plementation, and fidelity of the intervention.
WORTH is a Centers for Disease Control and Preven-
tion best practice intervention that was developed for in-
carcerated substance-using women [53]. The original
WORTH intervention has been adapted multiple times
and found to be efficacious in reducing condomless sex
and physical and sexual IPV among women who use
drugs in community corrections settings, including but
not limited to those supervised by New York City
Department of Probation as well as women in drug
treatment settings [3, 5, 21, 54]. In the 2009 trial of the
WORTH intervention (N = 337), 17% of the 221 black
female participants tested positive for HIV, and 30%
tested positive for at least one STI [21]. Rates of HIV in-
fection among white and Latina women in the original
WORTH trial were significantly lower [3]. The alarm-
ingly high HIV rate found among black participants in
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the original WORTH study is comparable to rates in
Sub-Saharan Africa and is suggestive of a concentrated
epidemic among black women who use drugs and are
also engaged in justice system supervision. The New
York City Department of Probation played a key role in
providing access to participants for the 2009 trial in vari-
ous probation sites. The New York City Department of
Probation also provided support in grounding 2009
WORTH study findings in terms of global HIV and STI
infection rates among community corrections popula-
tions as compared with the general population. In
addition, because E-WORTH is designed to be deliv-
ered in low-resource probation settings that are over-
burdened with high caseloads and lack professional
staffing and sufficient resources to implement HIV/STI
and IPV prevention services, we highlight the ways in
which E-WORTH advances the continuum of
cost-effective HIV prevention, testing, and treatment
interventions that may be scaled up in community cor-
rections settings nationwide.
Overview of study design and aims
This hybrid effectiveness trial aims to enroll 420 black
women who use controlled substances and must
undergo supervision at community corrections sites in
New York City. Eligible women are randomly assigned
to (1) E-WORTH, consisting of an individual stream-
lined HIV testing session followed by a four-session
group-based multimedia HIV/STI prevention interven-
tion (E-WORTH); or (2) an individual streamlined HIV
testing session alone (streamlined HIV testing), which
will serve as the comparison condition. Both conditions
are delivered by community corrections providers. Re-
peated assessments occur at baseline and 3, 6, and 12
months postintervention. We conduct repeated assess-
ments and qualitative interviews on multilevel factors
that may influence the effectiveness of both interven-
tions on study outcomes, and these are conducted with
probation providers delivering the interventions, front-
line probation staff, and probation administrators. This
study has the following specific aims:
1. To test the comparative effectiveness of E-WORTH
plus streamlined HIV testing versus streamlined
HIV testing alone on primary outcomes of decreas-
ing biologically confirmed HIV and other STIs and
the number and proportion of unprotected sex acts
at the 12-month follow-up and secondary outcomes
of reducing drug use, increasing use of drug treat-
ment, linkage to HIV care and antiretroviral therapy
adherence (for HIV-positive participants), and de-
creasing incidence of IPV and recidivism.
2. To test if the effectiveness of E-WORTH on study
outcomes is moderated by client characteristics
(e.g., client subgroups defined by sociodemographic
and psychosocial characteristics)
3. To estimate the costs and comparative cost-
effectiveness of E-WORTH plus streamlined HIV
testing versus streamlined HIV testing alone on STI
infection rates, drug use, and projected number of
HIV cases averted at the 12-month follow-up.
4. To examine qualitatively and quantitatively how
multilevel theory-driven factors may influence
the fidelity of implementation and effectiveness
of E-WORTH and streamlined HIV testing on
study outcomes.
Theoretical and conceptual framework
E-WORTH’s intervention is informed by a theoretical
framework that incorporates Empowerment Theory [51]
and Social Cognitive Theory [50, 55]. The study’s imple-
mentation science conceptual framework is guided by
the CFIR.
Theory
E-WORTH aims to elicit intrinsic motivation for reducing
HIV/STI risks, increase positive self-talk, enhance sexual
negotiation skills to refuse unsafe sex, develop strategies
and set goals for reducing sexual and drug risk behaviors,
enhance social support networks, improve relationship
safety and reduce risks for experiencing IPV, and identify
and link to services (i.e., general health and mental health
referrals, HIV care, and drug treatment programs).
Consistent with the tenets of Empowerment Theory [51]
and Social Cognitive Theory [50, 55], E-WORTH provides
participants with opportunities to develop self-efficacy
and practice mastery of sexual negotiation and
problem-solving skills to reduce risky behaviors through
interactive group activities. In light of the disproportion-
ately high percentage of black women who are involved
with the justice system, E-WORTH also infuses empower-
ment principles by raising awareness of structural forces
of sexism, racism, and institutionalized oppression that
originate from slavery and historical responses of resili-
ence and resistance among black women.
Conceptual framework of implementation
The CFIR has been widely adopted across a spectrum of
research disciplines [52, 56–62]. It provides a useful lens
through which to systematically examine key elements
needed to ensure successful intervention adoption, im-
plementation, fidelity, and sustainability. This innovative
framework guides the study’s (1) research design; (2) ex-
ploration of the potential barriers and facilitators of im-
plementation in a real world correctional setting; and (3)
the qualitative components, measurement, and analytic
plan for our mixed-methods aim. The specific domains
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of CFIR that have been applied to the implementation of
E-WORTH include the following:
 Outer setting: We define outer setting as New
York City Department of Probation and
community corrections policies and procedures
governing safety, facility access, and access to
potential enrollees as a whole impacting
recruitment techniques employed.
 Inner setting: Inner setting considerations include
various organizational characteristics of community
providers who serve women in community corrections
settings that we partnered with to deliver E-WORTH.
For the purposes of this article, we refer to this
provider as E-WORTH’s nongovernmental
organization (NGO) community provider. We also
refer to the NGO community provider personnel
that facilitate E-WORTH sessions as “facilitators.”
Inner setting characteristics include networks and
communication; culture, climate, and readiness for
implementation; and policies and procedures
related to participant engagement and support.
 Individuals in the organization: For E-WORTH, this
construct includes study personnel at recruitment
and implementation sites (e.g., probation, parole,
NGO community), readiness to adopt the intervention,
attitudes about technology (e.g., perception about
how hard it is to use, how hard it is to administer to
participants), and knowledge of and views about the
intervention.
 Intervention characteristics: Intervention
characteristics include features of the intervention
itself (the use of a tablet, adaptability, complexity,
design) that might compromise or facilitate
implementation.
 Implementation processes: We define
implementation processes as preplanning and early
engagement activities, training, supervision strategies
used, reflection and evaluation activities, fidelity
monitoring, and hiring practices used.
Figure 1 features the multilevel conceptual framework
for this intervention, which identifies applicable key
CFIR constructs [52] that enhance or diminish the deliv-
ery of E-WORTH and streamlined HIV testing in com-
munity corrections sites from early engagement through
adoption. Figure 1 also depicts the study’s intervention
and control arms along with the primary and secondary
outcomes.
Although we provide an overview of each domain, this
trial primarily evaluates CFIR’s inner setting. In consid-
ering the feasibility of implementing E-WORTH in se-
lected correctional settings, CFIR will aid us in
answering critical questions such as the following:
1. What are the optimal strategies to employ during
the preengagement phase to ensure sustainability
through implementation and beyond?
2. What are the ways to best to supervise facilitators
in correction settings?
3. What are the cultural considerations specific to
community corrections settings that may facilitate or
impede efforts to disseminate or scale up E-WORTH?
Community-based participatory research
Guided by CBPR principles of shared and equitable deci-
sion making in all aspects of the research process, the in-
vestigative team convened a multistudy community
advisory board during the preimplementation phase of the
study [63]. The advisory board, formally referred to as the
Community Collaborative Research Network (CCRN), is
comprised of formerly incarcerated and other justice-
involved men and women, New York City Depart-
ment of Probation representatives, New York City
Department of Health representatives, NGO commu-
nity leadership personnel, and not-for-profit service pro-
viders from a variety of settings who serve justice-involved
individuals. CCRN is guided by shared decision-making
processes that are a hallmark of CBPR, and board members
provide integral feedback on various aspects of
E-WORTH’s implementation processes, including but not
limited to participant outreach, recruitment, and retention.
CBPR principles also permeate other aspects of
E-WORTH’s adaptation and implementation. Prior to
the launch of the study, we held focus groups and
piloted the study with black women with active or recent
histories of justice involvement and substance use. Focus
group and pilot participants helped to refine the study’s
content, provide feedback on the newly Afrocentric
“look and feel” of the adapted intervention tool, and
tested the multimedia platform.
Also guided by the CBPR, the investigative team held
regularly scheduled strategic planning meetings with
NGO community facilitators and supervisory personnel
during the preimplementation phase of the study to dis-
cuss implementation logistics. In addition, we began hold-
ing weekly strategic planning calls with NGO community
personnel prior to the launch of the study to discuss more
granular implementation details, including but not limited
to marketing materials, staff training and supervision, and
study protocols. Advisory board meetings, focus groups,
and strategic planning meetings are being held continually
through the conclusion of the study.
Methods/design
Study sites
Participants are recruited from multiple corrections orga-
nizations and community-based organizations in New
York City recruitment sites, including the New York City
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probation and parole departments. We employ a variety
of recruitment strategies when promoting E-WORTH at
these locations. Columbia University project research as-
sistants (RAs) directly approach potential enrollees and
ask permission to talk to them about participation in the
study. Project personnel also post intervention flyers and
conduct presentations at each location.
The NGO community reentry provider with whom we
entered into a service agreement contract is the largest
nonprofit provider of services to community corrections
populations in New York City. NGO community reentry
sites in Manhattan and Queens serve as study sites. We
selected this provider on the basis of their 50-year his-
tory of providing a constellation of services, including
HIV testing and counseling, to justice-involved individ-
uals. The NGO provider identified multiple part-time fa-
cilitators (equivalent to one full-time staff member) who
met the following Columbia University criteria:
1. Must self-identify as African-American or black
women;
2. Must have 2 years of experience in HIV, substance,
and/or IPV care working with justice-involved pop-
ulations; and
3. Must have a high school diploma or equivalent degree.
Recruitment
For the randomized effectiveness trial component of this
study, we aim to recruit a total of 420 black women who
use controlled drugs and are involved in the criminal
justice system. We started enrolling participants in
November 2015 and will complete enrollment in May
2018. Women assigned to either intervention condition
(E-WORTH plus streamlined HIV testing or streamlined
HIV testing alone) will receive all services provided by
community NGO personnel. Women who test positive
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Fig. 1 Conceptual framework for hybrid type I features the multilevel conceptual framework for the E-WORTH intervention and identifies
applicable key Consolidated Framework for Implementation Research (CFIR) constructs [52] that enhance or diminish the delivery of Empowering
African-American Women on the Road to Health (E-WORTH) and streamlined HIV testing in community corrections sites from early engagement
through adoption. The figure also depicts the study’s intervention and control arms along with the primary and secondary outcomes. ART
Antiretroviral therapy, HIV Human immunodeficiency virus, STI Sexually transmitted infection
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counseling and linkage to treatment using the Centers
for Disease Control and Prevention’s Guidelines for
Counseling, Testing, and Referral. Figure 2, E-WORTH’s
Consolidated Standards of Reporting Trials (CONSORT)
diagram, provides a visual overview of all key stages in
the intervention and control arms from outreach and
screening through the 12-month follow-up assessment.
Trained Columbia University RAs distribute recruit-
ment flyers that provide a telephone number and basic
information regarding the intervention. Research staff
also recruit in the waiting areas at corrections locations.
If a woman expresses an interest in participating in the
intervention, RAs invite her to be screened in a private
room in an area away from community corrections (e.g.,
probation, parole) personnel and other corrections cli-
ents. The RA will obtain informed consent to be
screened by reading the screening consent form to the
participant and asking if she has any questions about the
screening interview before obtaining her signature on
the form. After obtaining informed consent, the RA will
conduct a 10–15-minute screening interview to deter-
mine eligibility and willingness to participate.
Table 1 lists E-WORTH eligibility criteria. To be eli-
gible, participants must meet all criteria.
Participants receive $5 for completing an initial screen-
ing. If they meet eligibility criteria for the intervention and
are willing to participate, an enrollment meeting will be
held at a community NGO provider site. Participants re-
ceive $55 for the baseline interview and $55, $60, and $65
respectively, for the 3-, 6-, and 12-month follow-up ap-
pointments. Compensation amounts include HIV and STI
testing and cover all study-related transportation costs.
Follow-up assessments are administered at a community
NGO provider location, Columbia University’s community
research site, or at a community corrections location (i.e.,
the probation or parole office from which the participant
was originally recruited) (Additional file 1). Figure 3 depicts
E-WORTH’s Standard Protocol Items: Recommendations
3-month follow up 
assessment (n=200)
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                        E-WORTH CONSORT FLOW DIAGRAM
Fig. 2 Empowering African-American Women on the Road to Health (E-WORTH) intervention flow. The figure depicts E-WORTH’s Consolidated
Standards of Reporting Trials (CONSORT) diagram and provides a visual overview of all key stages in the intervention and control arms from
outreach and screening through the 12-month follow-up assessment. HIV Human immunodeficiency virus
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for Interventional Trials (SPIRIT) figure and provides an
overview of the schedule and time commitment related to
the intervention and control arms.
The enrollment meeting consists of the following steps:
1. A computerized baseline assessment;
2. Testing for chlamydia, gonorrhea, and trichomoniasis;
3. Assignment to an intervention condition;
4. For those assigned to the intervention arm,
completion of a brief introductory session of the E-
WORTH intervention (session 1); and
5. A streamlined HIV test administered during session 1.
Table 1 Eligibility criteria for effectiveness trial
Inclusion criteria
Demographics Assigned gender at birth (female)
Identify as female
18 years of age or older
Identify as African-American or black
English-speaking
If participant is pregnant, she is less than 7 months pregnant
Has an address to receive mail
Lives in one of the five boroughs of New York City
Criminal justice
involvement
Supervised by a criminal justice entity, such as probation, parole, or alternative-to-incarceration program in
the past 90 days
Sexual risk behavior Reports engaging in unprotected vaginal or anal sex with a male partner in the past 90 days
Substance use risk Reports any illicit drug use or binge drinking or enrolled in alcohol or drug treatment in the past 6 months
Other substance use
or sexual risk
Reports at least one of the following outside risks:
1. Had more than one male partner in the past year
2. Injected drugs in the past year
3. Was ever diagnosed with human immunodeficiency virus (HIV), herpes, or genital warts
4. Was diagnosed with a sexually transmitted infection (STI), including gonorrhea, syphilis, chlamydia, trichomoniasis,
pubic lice, etc., in the past year
or
5. Has had sex with a male partner in the past year who she knows or suspects of having at least one of the following:
a. Partner is HIV-positive, positive for hepatitis C virus, or has herpes or genital warts
b. Partner has had any other STI in the past year
c. Partner has had sex with another person
Fig. 3 Empowering African-American Women on the Road to Health (E-WORTH) participant Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) figure. Provides an overview of the schedule and time commitment related to the intervention and control arms
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Informed consent will again be obtained, and a con-
firmatory screening also will be conducted for all par-
ticipants whose enrollment appointment occurs within
more than 24 hours of the date they were screened.
The study consent form indicates that research staff
may also contact participants at a future date to de-
termine if they may be interested in participating in
additional studies. The consent form also notes that
participation in future studies is completely voluntary.
Participants are given a copy of the consent form
and, upon request, all additional relevant study infor-
mation (e.g., copies of the research protocol). Partici-
pants assigned to either intervention condition also
receive a comprehensive referral manual tailored for
drug-using, justice-involved black women. The study’s
manual lists health, mental health, employment, gen-
eral services, and treatment resources throughout
New York City.
Participants are enrolled at the community NGO pro-
vider site of their choice (typically one close to their
place of residence) by Columbia University RAs.
Appointments are held on the day participants are
screened or at the potential participant’s earliest con-
venience. Columbia University personnel complete steps
1 and 2 of the enrollment meeting; community NGO
staff complete the remaining steps. Appointments are
held in the computer laboratory or conference room
areas of the NGO community reentry location.
Assignment into an intervention arm takes place on
the day and at the time of the enrollment meeting. If a
participant indicates that they are not able to stay for
the portion of the enrollment appointment in which they
are assigned to an intervention arm, steps 3–5 are not
completed. The participant will instead be asked to re-
turn on the very next business day they are available.
Participants must be assigned to an intervention arm
within 45 days of their initial visit. If the participant is
not available within this time frame, she must again
complete the computerized baseline assessment and
then complete session 1 and be tested for HIV.
Randomization
Consistent with an intention-to-treat approach for data
analyses, participants are considered enrolled in the trial
only after they are assigned to an intervention arm dur-
ing their enrollment appointment. Assignment to an
intervention condition occurs at both community NGO
locations concurrently but independently; that is, the
numbers and timing of randomization and launching of
intervention groups in one site does not affect assign-
ments or launching in the other intervention location.
We balance first by intervention condition and second
by the community NGO site at which the enrollment
interview is completed. To ensure that a comparable
number of participants enter the intervention and con-
trol conditions at a given study site, we use a hybrid
randomization approach in which participants are both
randomly and “purposefully” assigned to an intervention
condition. Allocation sequences are automatically gener-
ated using an Excel spreadsheet (Microsoft, Redmond,
WA, USA) managed by the study’s project director. Pe-
riods of randomization are automatically followed by pe-
riods of purposeful assignments. To eliminate bias
during periods of “purposeful” assignments, we adhere
to fixed randomization and assignment windows gov-
erned both by calendar days and by the total time it
takes enroll the requisite number of women to launch a
new intervention group.
Intervention condition: E-WORTH and streamlined HIV testing
Consisting of the individual introduction to E-WORTH
and streamlined HIV testing session followed by four
90-minute group sessions, E-WORTH optimizes group
and individual modalities in a hybrid intervention de-
sign. Group sessions feature an “in-room” facilitator who
provides support and guidance through group opening
and closing activities. In addition, E-WORTH employs
computerized interactive exercises and video testimo-
nials of women through the aid of a tablet-based
“online” narrator that leads participants through com-
puterized self-paced modules.
Figure 4 provides an overview of each intervention
session. It also provides an overview of the core ele-
ments (components) of the intervention. E-WORTH’s
core components (see Fig. 3) include raising awareness
about different types of HIV/STI risks, promoting HIV
testing and counseling, enhancing motivation and link-
age to HIV/STI treatment and drug treatment, and
teaching risk reduction problem solving. Participants
also learn negotiation skills and establish risk reduction,
general service, and social support goals. Embedded in
the multimedia platform are tools for IPV, safety plan-
ning, and referral to IPV services. The computerized tool
also aids in social support building for risk reduction
and relationship safety, and it features fictional charac-
ters that model core skills and positive peer norms.
E-WORTH’s core elements are designed to raise partici-
pants’ awareness about different types of HIV/STI risks
and increase their motivation for testing, counseling,
and treatment. E-WORTH’s core elements are de-
signed to raise participants’ awareness about different
types of HIV/STI and IPV risks and increase their
motivation for testing, counseling, and treatment.
E-WORTH also aims to decrease the incidence of
IPV at follow-up assessments.
E-WORTH group sessions are delivered in a trad-
itional paper-based group setting by a trained NGO
community reentry facilitator, but the sessions also have
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computerized self-paced modules that individual members
complete on tablets. This hybrid group modality, in which
about half the session activities are delivered as computer-
ized self-paced modules, was found to be efficacious in re-
ducing unprotected sex compared with an attentional
Wellness Promotion control group [3, 64]. E-WORTH’s
innovative multimedia components include the use of nar-
ratives and videos with fictional characters who portray
different life stories of predominantly black women af-
fected by HIV/AIDS, STIs, drug use, and criminal justice
system involvement. The intervention also provides in-
struction and demonstration of core skills (e.g., safer sex
negotiation and problem-solving skills, technical con-
dom use skills) through the use of culturally congru-
ent role models. Participants also complete individual
computerized exercises and logs designed to enhance
recall of core knowledge and to provide a confidential
space for participants to track their individual pro-
gress in reducing risky behaviors and achieving risk
reduction goals.
Facilitator training, technical assistance, adherence, and
supervision
All NGO community facilitators receive a 4-day training
led by Columbia University personnel on how to deliver
the E-WORTH intervention. Facilitation training focuses
on developing competency on the core components of
the E-WORTH intervention using Motivational Inter-
viewing (MI) techniques. MI is an evidence-based,
participant-centered treatment technique with proven
efficacy in people with mental health and substance use
disorders [65]. MI is a strengths-based approach that
supports and promotes client self-efficacy, expresses em-
pathy, and motivates clients to change self-destructive
behaviors.
Columbia University personnel meet with NGO com-
munity provider facilitation and supervisory personnel
on an as-needed basis to coordinate study implementa-
tion activities and delivery. The NGO provider also as-
signs one manager at each study site to provide integral
logistical support in navigating implementation
CORE ELEMENTS
Raise awareness about 
different types of HIV/STI 
risks
HIV testing and counseling
Enhance motivation and 
linkage to HIV/STI treatment 
and drug treatment




screening for IPV, safety 
planning and referral to IPV 
services
Enhancing social support for 
risk reduction and 
relationship safety
Risk reduction, service and 
social support goal setting
Use of fictional characters to 
model core skills and positive 
peer norms
Identify service, risk 
reduction, social support and 
health care needs
E-WORTH CORE ELEMENTS & SESSIONS
Session 2 - (Group Session) Introduction to five narrative 
characters of women (3 Black, 1 White, 1 Latina) affected by HIV/AIDS, drug use 
and criminal justice involvement; (2) Raise awareness of the high rates of HIV/STIs 
among Black women (3) Correctly identify HIV/STI transmission risks though 
interactive exercises and video clips (4) Discuss personal reasons to stay healthy 
and protect themselves and their communities from HIV/STIs. Review of session 1 
goals. General services and risk reduction goal setting.
Session 1 - (Individual Session) Orientation + Streamlined HIV 
testing. Resiliency of Black women highlighted and disproportionate risks to African-
American women explored. General services goal setting.
 Session 3 - (Group Session) 
Managing Risk (1) Introduction of problem solving (POP) techniques; (2) Identify 
drug-related, intimate partner violence, and criminal justice triggers for unsafe sex 
using interactive exercises: (3) Use POP to work through barriers and practice 
correct condom placement skills for female condoms; and (4) Create computerized 
social support network map. Review of session 2 goals. General services, social 
support and risk reduction goal setting.
Session 4 - Group Session) Safer Sex Negotiation and 
Managing Drug use: 1) Introduce, model and role play negotiation skills for safer 
sex and drug use through simulated vignettes (2) Revisit social support network 
map; (3) Identify factors that can increase risk through drug and alcohol use and 
review strategies for safe injection practices; and (4) Develop personalized safety 
plan. Review of session 3 goals. General services, social support and risk reduction 
goal setting.
Session 5 - (Group Session) Safety Planning (1)) 
Raise awareness of connections between IPV, drugs and engaging in unsafe 
behaviors; and (2) Review of all concepts from sessions 1-4. Review of session 5 
goals. Risk reduction goal setting.
Fig. 4 Empowering African-American Women on the Road to Health (E-WORTH) core elements and sessions. The figure provides an overview of
each intervention session. It also provides an overview of the core elements (components) of the intervention. HIV Human immunodeficiency
virus, IPV Intimate partner violence, STI Sexually transmitted infection
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challenges as they arise. Challenges include but are not
limited to participant access to community NGO sites,
technological failures and Wi-Fi access issues, and staff
scheduling emergencies. Columbia University and NGO
supervising staff are also on-call to assist facilitators in
the event of clinical emergencies that may emerge with
group participants.
E-WORTH’s multimedia platform records attendance
data for each intervention session and information on
number and general type of referrals to services using
participant identification numbers. NGO community
provider facilitation personnel also complete a session
adherence form for each session that assesses the extent
to which core elements and activities of the session are
covered and the quality of delivery of each activity using
a rating scale. In addition, the computerized multimedia
E-WORTH tool will generate data on whether partici-
pants completed each session activity and the amount of
time spent on each activity.
NGO facilitators also receive biweekly group supervi-
sion by conference call with Columbia University’s
E-WORTH project director or a member of the study
investigative team. During supervision calls, facilitators
review session adherence forms, discuss challenging situ-
ations that arise, and develop strategies for responding
to such challenges in the future. E-WORTH’s project
director is also available for technical assistance calls as
needed related to challenges with implementing comput-
erized modules or specific requests for individual super-
vision from facilitators. We collect data on the nature
and type of technical assistance requests and clinical
emergencies that occur, as well as on the attendance of
participants and content covered in clinical supervision
calls. Standard services at the NGO community reentry
provider site are offered to participants randomized to
both intervention conditions. Core programming in-
cludes social services, HIV testing and counseling,
on-site and off-site substance abuse and mental health
treatment referrals, and educational and vocational
services.
Control condition: streamlined HIV testing
Community NGO facilitators deliver a 5-minute HIV
testing information session in a private space to partici-
pants assigned to the control condition. During the in-
formation session, facilitators describe the rapid testing
procedure as well as the timing for and meaning of test
results, and they explain the window period during
which an antibody test might be negative. Facilitators
briefly describe what HIV infection is and give partici-
pants HIV testing kit material, which provides an over-
view of transmission risks and effective strategies for
reducing risk. This streamlined HIV testing intervention
is consistent with New York State law and does not
require risk reduction counseling at the time of HIV
testing. The streamlined HIV testing alone condition has
been tested and found to be effective in two large-scale
multisite studies conducted in the National Institute on
Drug Abuse (NIDA) Clinical Trials Network [47, 48].
Retention
RAs are trained to engage participants in identifying and
overcoming barriers to attendance at follow-up sessions.
We use a variety of retention strategies, including ad-
ministering a detailed locator package at baseline,
assigning cases to RAs to track from baseline to the
12-month follow-up, and updating locator data at every
assessment. Because the study involves participants who
are completing community corrections sentences, there
is a likelihood that some participants may become incar-
cerated. If that does occur, the study’s adverse events
protocol will be followed, and the participant’s involve-
ment in the study will be discontinued. In addition, dur-
ing the informed consent meeting, potential participants
are apprised that they may withdraw from the study at
any time. In the event that a participant voluntarily with-
draws from the study or the investigator decides to dis-
continue a participant owing to an adverse event, no
additional assessment data are collected.
Criteria for discontinuing or modifying intervention
The study protocol provides for ancillary and posttrial
care and compensation for participants who are deemed
to have suffered. Data on adverse events, including those
that are psychological in nature, are systematically col-
lected during the trial and reported to the principal in-
vestigative team and the study’s institutional review
board (IRB) in order to ensure appropriate management
of the adverse events as well as to have full documenta-
tion of the events for all conditions. Adverse events are
also reported to the study’s IRB and data and safety
monitoring board (DSMB). The DSMB consists of four
expert members in the field who are experienced with
HIV treatment, substance abuse treatment, and vulner-
able populations, all of whom have no conflict of interest
with regard to the study. The DSMB oversees and pro-
vides advice to the principal investigative team on the
continued scientific integrity and safety of the imple-
mentation of the trial. The DSMB reviews the status of
recruitment, retention, successes, barriers and challenges
of the implementation of the trial, adverse events, and
the reporting procedures of adverse events. Two interim
analyses will be conducted in addition to the planned
“final” analyses at the conclusion of the proposed study.
The DSMB will review findings from the interim analysis
and determine whether the study needs to be terminated
for safety reasons. Data will be sent to the DSMB 1 week
prior to the meeting. The DSMB meets twice per year.
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The meetings are face-to-face, and minutes taken at the
meeting are archived.
Interim analyses use complete data over the longest
follow-up duration (i.e., the 12-month assessment time
point). The principal investigators and coinvestigators
will be unblinded to the interim analyses, but the study
staff will be blinded. The interim analyses will be con-
ducted by the statistician on the study, and the results
will be reported to the principal investigators. With re-
spect to efficacy, stopping rules following an interim
analysis focus on demonstrable benefit in the sample
and based on data accrued to date.
Monitoring fidelity of implementation: process measures
and quality assurance procedures
We employ several strategies endorsed by the Centers
for Disease Control and Prevention Capacity Building
Branch for the dissemination of evidence-based inter-
ventions to enhance fidelity and monitor “intervention
drift.” Our strategies include the following:
1. Providing standardized training and ongoing super-
vision for NGO community reentry facilitators who
deliver both conditions to enhance competency;
2. Scheduling regular site visits to meet with NGO
community reentry partners to discuss challenges
and assess quality and fidelity of implementing both
conditions;
3. Collecting data on number and type of technical as-
sistance requests;
4. Monitoring sessions for both conditions by listening
to a randomly selected percentage of audio-recorded
sessions for quality assurance to rate how closely
facilitators adhere to the intervention protocol and
the overall clinical quality of delivery each session
activity; and
5. Regularly reviewing E-WORTH’s fidelity assessment
tool, which records how much time is spent on the
activity and records individual participant responses
to risk ratings and goal setting.
The use of E-WORTH’s fidelity assessment tool
along with the collection of process measures also al-
lows us to rigorously monitor the fidelity of imple-
menting E-WORTH plus streamlined HIV testing and
streamlined HIV testing alone conditions.
Procedures to handle treatment contamination
Because participants are randomized at NGO community
reentry provider intervention sites and may have some
interaction with other potential enrollees, there is a risk of
contamination between intervention and control arms.
We employ a variety of quality assurance measures to
minimize or avert contamination risks between treatment
conditions. All recruitment and randomization activities
are completed under the supervision of Columbia
University’s leadership personnel, and RAs are blinded to
the randomization process. In addition, all enrollment
meetings and E-WORTH intervention sessions are held in
private areas to minimize contact between participants
randomized to intervention and control arms. Research
staff are also trained to identify and investigate any de-
tected instance(s) of contamination between intervention
arms and engage in immediate corrective action.
Measures
Participants complete computerized assessments at
baseline and at the 3-, 6-, and 12-month follow-up
marks. Columbia University RAs schedule all follow-up
appointments and meet with participants at intervention
sites. Table 2 provides a description of E-WORTH’s ef-
fectiveness trial measures.
Power analysis
For E-WORTH’s primary outcome, we used intraclass
correlation estimates based on previous WORTH trials,
and variance inflation factors were calculated to generate
effective sample sizes used in G*Power for the effective-
ness aim. For the target sample size calculation, we se-
lected cumulative STI incidence for our power analysis,
given that it is our primary outcome and that it had the
lowest power among the other outcome variables, and
we assume a 50% reduction (on a background cumula-
tive incidence of 20.5%) to be clinically meaningful to
detect via Poisson regression. For behavioral outcomes,
projected means and SDs allow for effect size f2 to be
calculated and used in G*Power [66]. Results for primary
outcomes indicate that 80% power is achieved for the
rate-limiting outcome (i.e., cumulative STI incidence)
with an effective sample size of 372 participants, trans-
lating to a sample size of 378 participants after account-
ing for intraclass estimates. We then increased the
starting sample size to 420 to safeguard against attrition.
Cost-effectiveness
In response to the need for greater transparency regarding
the allocation of limited federal funding for scientific re-
search, cost-effectiveness analytical techniques have in-
creasingly been used in evidenced-based research [67, 68].
Despite this fact, scientific guidelines for deciding how
best to allocate scarce resources to promote uptake of
cost-efficient HIV services in correctional settings have yet
to be developed. Although it is true that cost-effectiveness
is only one of many considerations when disseminating
research into practice settings, the importance of
cost-effectiveness in correctional settings marked by fund-
ing constraints and limited human resources cannot be
minimized. E-WORTH also addresses this gap. We aim to
prospectively evaluate costs of delivering E-WORTH and
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Table 2 Effectiveness trial measures
Variable type Construct Description Timeline
Primary
outcome
Reduced incidence of biologically
confirmed STIs (i.e., chlamydia,
gonorrhea, and trichomoniasis)
Biological assay for infection by Chlamydia trachomatis,





HIV risk behaviors (number of unprotected
sex acts; self-reported condom use)
Measured using NIDA’s Seek, Test, Treat and Retain for
Vulnerable Populations: Data Harmonization Measure
Sexual risk behavior items are based on the Women’s




Viral load Written confirmation of viral load information for HIV-positive




Drug use Measured using NIDA’s Seek, Test, Treat and Retain for
Vulnerable Populations Data Harmonization Measure





Use of drug treatment Single-item question that inquires about participant’s
current legal criminal justice status
Participants are asked to select all responses that apply,




Intimate partner violence IPV was assessed using three subscales from the Revised





We also used the four-item Jellinek Inventory for assessing
Partner Violence [72].
Baseline
Last, we assessed IPV using a two-item self-efficacy inventory that
gauges participants’ attempts to make or update a safety plan,




Linkage to and retention in HIV
and STI treatment
We assessed linkage to and retention in HIV and STI treatment





ART adherence We also assessed linkage to and retention in HIV and STI







Self-reported items assessing number of times stopped, detained,




Moderators Sociodemographics Self-reported data collected on age, gender, race/ethnicity,
education, income, and marital status.
Baseline
Psychosocial characteristics Depression is assessed using the four-item Center for




Posttraumatic stress experienced in the past month was assessed
using the PCL-C [73],
a standardized self-report rating 17-item scale that corresponds
to the key symptoms of PTSD.
Baseline, 12-month
follow-up
We use the Stressful Life Events Screening Questionnaire to assess
lifetime exposure to traumatic events [74].
Baseline
CFIR construct: outer setting
(Environmental-level characteristics)
Questions that focus on the external environment of all recruitment
and intervention locations (i.e., probation sites, NGO community
reentry provider locations, recruitment locations, strategies and
techniques). Assessed using structured qualitative interviews and
computerized surveys administered to NGO community reentry
facilitators at repeated time points.
Ongoing
CFIR construct: inner setting
(organization-level characteristics)
Items inquiring about the feasibility of implementing the
intervention in all identified locations; the structural characteristics,
networks and communication, culture, climate and readiness for
implementation of the implementation organization, recruitment
sites and probation locations. Also assessed using structured
qualitative interviews and computerized surveys administered to
NGO community reentry facilitators at repeated time points.
Baseline, repeated
assessments
CFIR construct: individuals setting Self-reported questions that capture NGO community reentry Baseline, repeated
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streamlined HIV testing by generating comparative
cost-effectiveness data that will enable policy makers and
program administrators to identify the most appropriate
HIV/STI interventions for criminal justice settings. The
technological components of E-WORTH also have con-
siderable cost and sustainability implications because
E-WORTH requires a lower degree of professional educa-
tion, training, and supervision to deliver.
We define cost-effectiveness as the incremental cost of
delivering E-WORTH divided by two intervention out-
comes: (1) differences in biologically observed STIs
(chlamydia, gonorrhea, and trichomoniasis) and (2) dif-
ferences in biologically confirmed HIV cases between
the E-WORTH intervention arm and streamlined HIV
testing and the streamlined HIV testing alone arm. In
addition, we will explore cost-related considerations as-
sociated with implementing E-WORTH in a real-world
setting.
We will collect intervention-specific cost data from a
variety of sources to calculate the incremental cost of
delivering E-WORTH. Cost data include the following:
(1) capital costs (e.g., space/rent information provided
by the NGO community reentry provider sites); (2) sal-
ary/personnel/labor information (e.g., total time spent
on intervention preparation and delivery based on
self-reported time sheets); (3) cost spent on study partic-
ipants: goods, supplies, travel reimbursement, and test
kits; and (4) research-related intervention costs (e.g.,
staff time spent supervising intervention facilitators).
Data analyses
Effectiveness trial: aims 1 and 2
The analytic approaches used for E-WORTH are built
upon the investigative team’s prior HIV prevention
randomized controlled trials, which involve an
intention-to-treat approach, handling missing data using
multiple imputation, and conducting sensitivity analyses
to quantify robustness of findings on the basis of models
and their assumptions. Descriptive statistics will
characterize the sample and measurement distributions
to ensure proper application of multivariate methods.
We will use multiple imputation to handle missing data.
Preliminary analyses include bivariate analyses to iden-
tify unadjusted associations among variables. Variables
significantly associated with outcome variables and attri-
tion, as well as significantly different across intervention
arms, will be included as covariates during hypothesis
testing. We have also constructed a qualitative dataset
that will aid in data analysis of key themes that emerge.
Cost-effectiveness: aim 3
To better understand cost-related considerations associ-
ated with implementing E-WORTH in a real-world set-
ting, qualitative interviews also will be conducted with
implementation facilitation and supervisory personnel
focusing on staff turnover, training, and staff supervision
needs. Interview findings will aid us in determining how
best to scale up E-WORTH after the clinical trial has
been completed. We anticipate substantially lower statis-
tical power for observed HIV seroconversions than for
STIs. As a result, for the HIV outcome “denominator” in
the cost-effectiveness calculation, we will use an “HIV
infections averted” estimate using data from the trial on
HIV risk behavior and a model of HIV transmission
used in HIV epidemiology and cost-effectiveness litera-
ture [69, 70]. Sensitivity analyses will also be performed
(e.g., using highest and lowest reported values for model
parameters reported among different studies) to ascer-
tain the extent to which cost-effectiveness conclusions
are robust to parameter assumptions.
Table 2 Effectiveness trial measures (Continued)
Variable type Construct Description Timeline
(staff-level characteristics) facilitators’ readiness to adopt the intervention; knowledge and
beliefs about the intervention that might influence adoption;
self-efficacy regarding ability to deliver the intervention; individual
identification with organization; attitudes about technology
(e.g., perception about how hard it is to use, how hard to




Determined using self-reported survey questions, this construct
examines: community reentry facilitators’ and organizational
providers’ attitudes towards the intervention; and features of the
intervention itself (the use of a tablet to deliver the intervention,




CFIR construct: process These self-reported inventory items captures and processes
activities associated with preplanning and early engagement




Abbreviations: ART Antiretroviral therapy, CFIR Consolidated Framework for Implementation Research, HIV Human immunodeficiency virus,
IPV Intimate partner violence, NGO Nongovernmental organization, NIDA National Institute on Drug Abuse, PCL-C Posttraumatic Stress Disorder
Checklist–Civilian version, PTSD Posttraumatic stress disorder, STI Sexually transmitted infection, STTR Seek, Test, Treat and Retain
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Implementation: aim 4
Guided by the CFIR, we will collect quantitative and
qualitative data to identify multilevel factors and pro-
cesses that enhance or diminish the fidelity of imple-
mentation, such as perceptions about the benefits and
disadvantages of delivering the intervention at their site,
perceptions of clients’ reactions to the intervention,
perceptions of the organizational climate of their
probation site, and their attitudes toward criminal justice
as a whole and HIV/STI interventions targeting
substance-using women. We will administer structured,
computerized assessments to NGO community reentry
providers, probation and parole providers, and various
community corrections personnel. Survey questions will
include items related to sociodemographics and profes-
sional training of staff and providers, attitudes toward
the E-WORTH and streamlined HIV testing and the
streamlined HIV testing alone conditions, level of
self-efficacy in delivering interventions, organizational
readiness to change, and organizational climate. From
an implementation perspective, attitudes about technol-
ogy (e.g., perception about how difficult it is to use, how
complex it is to administer to participants, how expen-
sive might it be for the community-based organization
(CBO) to operate) will have an impact on an organiza-
tion’s choice whether to implement it. Figure 5 provides
an overview of each study time point related to provider
assessments and interviews.
Integration of qualitative and quantitative findings
As a final step, we will integrate all qualitative and quan-
titative results using the E-WORTH multilevel CFIR in-
formed conceptual framework to triangulate findings
and provide a full picture of mechanisms that influence
the fidelity of implementation and the effectiveness of
the intervention. We will conduct multilevel, parallel
mixed data analysis to isolate findings that emerge from
each method and to clarify its transferability. We will
separately analyze quantitative and qualitative compo-
nents and generate inferences and conclusions in each
aim. We will then make metainferences by integrating
inferences obtained from all study strands [67]. Because
parallel analysis can lead to convergent or divergent
metainferences, we will use these as opportunities to
clarify applicability of theory, methodologies, and inter-
pretations to broader contexts.
Data management and confidentiality of study data
Data management activities and procedures use electronic
data management systems designed to enhance the effi-
ciency, security, and integrity of study data. Data collected
using computer-assisted self-interviews (CASIs) during
baseline and follow-up assessments are automatically re-
corded/stored by the computer. As respondents move
through computerized assessments, responses are
encrypted for transit between the respondent’s browser
and the study’s server using SSL and 128-bit encryption.
All qualitative interviews will be audio-recorded and
transcribed. We will construct a qualitative dataset that
will include identification of each transcript as well as
inclusion of relevant demographic data by provider/pro-
bation staff and by probation site that will aid in data
analysis of key themes that emerge. A preliminary set of
analytic coding categories (closed codes) will be assem-
bled on the basis of concepts, ideas, themes, and pat-
terns that characterize multilevel theory-driven factors
or processes described above. This set of codes will be
continually updated through a process of contrast and
comparison. The initial or open-coded data are then or-
ganized under the analytic category list. Digital record-
ings of in-depth qualitative interviews, in-depth
qualitative interview transcripts, and survey data from
Fig. 5 Empowering African-American Women on the Road to Health (E-WORTH) project Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) figure. Provider study-related items. The figure provides an overview of each study time point related to provider
assessments and interviews. CASI Computer-assisted self-interview, NGO Nongovernmental organization
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the CASI interview will be assigned a study identifier
code. Digital audio recordings are also uploaded for
quality assurance protocols. Only the principal investiga-
tors and the study’s project director have
password-protected access to the encrypted file linking
names of participants and their study identifier codes.
Participants will be assigned a unique identifier code
that is different from their study identifier code to log
into the multimedia platform. The file linking the multi-
media platform identifier and the study identifier will be
accessible only to the principal investigator and the
study’s project director. The multimedia platform will
only collect use data regarding the resources in the pro-
gram. The program will not collect personally identifying
information. Use data that are collected by the multi-
media platform will be password-protected and access-
ible only to the principal investigator and the study’s
project director.
Community corrections and NGO community reen-
try providers will not seek access to any personally
identifying study data provided by individuals or com-
munity corrections employees collected by Columbia
University. Columbia University will provide commu-
nity corrections and NGO community reentry
personnel with aggregated findings in a final project re-
port at the conclusion of the study. The identities of
study participants and employees will be masked in this
report and any report produced by Columbia University
such that it will not be possible to identify individuals
using information provided in the report.
Discussion
The intertwined risks of HIV/STI transmission and IPV
for black women who use drugs and are undergoing com-
munity correction remain extremely high. Adapting
evidence-based HIV/STI and IPV prevention interventions
such as the original WORTH intervention for this popula-
tion holds tremendous promise for addressing this public
health crisis. To date, there have been no HIV/STI and
IPV prevention interventions specifically directed toward
helping black women in community corrections gain more
knowledge about their HIV/STI status and become more
resilient and self-protective of their health and safety.
By targeting drug-using black women specifically, the
subset of the justice-involved female population at the
highest risk for HIV/STIs and IPV, this study advances
understanding of culturally tailored strategies to enhance
the protective practices of this target population of black
women. Community correction settings provide an un-
tapped venue for reaching this highly vulnerable but
difficult-to-engage population. Nevertheless, strategies
for implementing HIV/STI and IPV interventions in
organizational settings that serve this population are as
yet poorly understood.
This hybrid type I design protocol addresses this gap.
Lessons learned from the experiences of correctional
personnel in delivering this intervention will bridge the
informational gap between research and implementa-
tion science in this context. Key areas of focus include
community corrections provider attitudes toward
E-WORTH. Data gathered will explore the ways in
which features of the intervention itself (adaptability,
complexity, design) might impede or facilitate imple-
mentation. E-WORTH will also offer useful insight re-
garding optimal strategies to use when recruiting,
training, and supervising providers in correctional set-
tings who deliver interventions of this type. In addition,
E-WORTH will provide invaluable information on what
is required organizationally to run a culturally tailored
group intervention for black women who use drugs in a
real-world correctional setting.
Through its innovative design in implementing a
group-based modality that includes a computerized
self-paced tool in a community correction setting, this
study provides a unique lens through which to under-
stand the best strategies to employ this hybrid modality
with technology in nonprofit settings as a whole and
specifically in settings serving justice-involved popula-
tions. The use of fictionalized characters and simulated
video vignettes to portray different life stories of black
women affected by HIV/STIs, IPV drug use, and crim-
inal justice involvement highlights E-WORTH’s innova-
tive use of technology to deliver culturally congruent
messaging tailored specifically for this population.
E-WORTH’s online narrator also offers important
insight regarding ways to creatively use technology to
extend the reach of traditional “in the room” facilitators
in delivering interventions in correctional settings. It
also has important implications for expanding the use of
technology to extend the reach of criminal justice pro-
viders in engaging hard-to-reach justice-involved women
who remain at risk of HIV/STIs. The partially self-paced
format points in the direction of either the need for less
facilitator involvement or the possibility of administering
the intervention to larger numbers of participants at one
time, which has an impact on cost.
The analytic methods we employ in rigorously evaluat-
ing effectiveness and cost-effectiveness meet a NIDA
funding priority while providing valuable data regarding
the true cost of implementing studies such as
E-WORTH in criminal justice settings. This is of par-
ticular importance, given the long-term financial and
public health implications associated with engaging this
high-risk but difficult-to-reach population. Although the
value of averted HIV/STI cases cannot be fully quanti-
fied, cost-effectiveness calculations provide a useful and
objective lens for evaluating the incremental cost of the
E-WORTH intervention delivery by outcome. This too
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meets an important need in light of the current climate
of budgetary cuts for scientific research and the limited
availability of resources in nonprofit settings.
This study is designed to yield important data on vari-
ous innovative approaches we employ in Project
E-WORTH that have not been used, to our knowledge,
in implementation science research. For example, we
will examine the process by which we have embedded
services tailored specifically for black women into
organizational settings that provide services to men and
women from all racial and ethnic backgrounds. We will
identify the organizational benefits and challenges en-
countered in targeting E-WORTH for black women spe-
cifically and the potential impact on organizational
climates. We will also identify effective strategies to use
when recruiting intervention participants from various
correctional settings. Additionally, we will assess the ef-
fectiveness of the CBPR strategies we used when intro-
ducing HIV and STI risk reduction and IPV prevention
services into correctional settings.
Trial status
Trial recruitment started in November 2015. Recruit-
ment is ongoing. The project is scheduled to end on
June 30, 2019.
Additional file
Additional file 1: SPIRIT 2013 checklist: recommended items to address
in a clinical trial protocol and related documents. (DOC 138 kb)
Abbreviations
ART: Antiretroviral therapy; CASI: Computer-assisted self-interview;
CBPR: Community-based participatory research; CCRN: Community
Collaborative Research Network; CFIR: Consolidated Framework for
Implementation Research; CONSORT: Consolidated Standards of Reporting
Trials; DSMB: Data and safety monitoring board; E-WORTH: Empowering
African-American Women on the Road to Health; HIV: Human
immunodeficiency virus; IPV: Intimate partner violence; IRB: Institutional
review board; MI: Motivational Interviewing; NGO: Nongovernmental
organization; NIDA: National Institute on Drug Abuse; PCL-C: Posttraumatic
Stress Disorder Checklist–Civilian version; PTSD: Posttraumatic stress disorder;
RA: Research assistant; SPIRIT: Standard Protocol Items: Recommendations for
Interventional Trials; STI: Sexually transmitted infection; STTR: Seek, Test, Treat
and Retain; WORTH: Women on the Road to Health
Acknowledgements
We are indebted to the E-WORTH study team, the community NGO provider,
the New York State Department of Probation, and lastly the E-WORTH study
participants for making this study possible.
Funding
The study was funded by a NIDA grant (R01DA025878 [to LG]). The funders
had no role in study design, data collection and analysis, decision to publish,
or preparation of the manuscript. MLW is supported by institutional funds
from the New York State Psychiatric Institute.
Dissemination policy—authorship
Topics suggested for presentation of publication will be circulated to the
principal investigators. The person making the suggestion may be
considered as the lead author. The PI of an ancillary study should be
considered for lead author of material derived from this study. Disputes
regarding authorship will be settled by the principal investigator.
Authors’ contributions
LG is the principal investigator of this study. LG, NEB, TH, EW, LM, SR, KJ, and
DGE contributed to the design, conceptualization, and implementation of
the study. KJ, LG, NEB, EW, and TH developed and drafted the protocol
manuscript. MLW provided critical review of the manuscript. All authors read
and approved the final version of the manuscript.
Ethics approval and consent to participate
This research was performed in accordance with the Declaration of Helsinki
and approved by the institutional review board at Columbia University (no.





The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1University of Alabama School of Social Work, Little Hall, 670 Bonner Drive,
Tuscaloosa AL 35401, USA. 2Department of Sociomedical Sciences, Mailman
School of Public Health, Columbia University, 722 West 168th Street, New
York, NY 10032, USA. 3Social Intervention Group, Columbia University
Teacher’s College, 1255 Amsterdam Avenue, New York, NY 10027, USA. 4The
Fortune Society, 625 West 140th Street, New York, NY 10031, USA. 5New York
City Department of Probation, 210 Joralemon Street, Brooklyn, NY 11201,
USA. 6Center for Teaching and Learning, Columbia University, Lewisohn Hall,
2970 Broadway #603, New York, NY 10027, USA. 7Columbia University / New
York State Psychiatric Institute, 1051 Riverside Drive, #24, New York, NY
10032, USA. 8Columbia University School of Social Work, Social Intervention
Group, 1255 Amsterdam Avenue, New York, NY 10027, USA.
Received: 11 April 2018 Accepted: 6 July 2018
References
1. Altice FL, et al. Correlates of HIV infection among incarcerated women:
implications for improving detection of HIV infection. J Urban Health. 2005;
82(2):312–26.
2. Inciardi JA, et al. HIV and other infectious diseases among drug-involved
offenders. J Psychoactive Drugs. 2008;40(4):423–6.
3. El-Bassel N, et al. Efficacy of a group-based multimedia HIV prevention
intervention for drug-involved women under community supervision:
project WORTH. PLoS One. 2014;9(11):e111528.
4. Rowell-Cunsolo TL, El-Bassel N, Hart CL. Black Americans and incarceration: a
neglected public health opportunity for HIV risk reduction. J Health Care
Poor Underserved. 2016;27(1):114–30.
5. El-Bassel N, et al. Women in community corrections in New York City: HIV
infection and risks. Int J STD AIDS. 2017;28(2):160–9.
6. Pelligrino N, et al. Incarcerated black women in the southern USA: a
narrative review of STI and HIV risk and implications for future public health
research, practice, and policy. J Racial Ethn Health Disparities. 2017;4(1):9–18.
7. Centers for Disease Control and Prevention (CDC), Division of STD
Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention. STDs in racial and ethnic minorities. https://www.cdc.gov/std/
stats15/minorities.htm. Accessed 23 Aug 2017.
8. Centers for Disease Control and Prevention (CDC), Division of STD Prevention,
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. HIV and
African Americans. https://www.cdc.gov/hiv/pdf/group/racialethnic/
africanamericans/cdc-hiv-africanamericans.pdf. Accessed 23 Aug 2017.
9. Centers for Disease Control and Prevention (CDC), Division of STD
Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB
Johnson et al. Trials  (2018) 19:486 Page 17 of 19
Prevention. HIV and women. https://www.cdc.gov/hiv/pdf/group/gender/
women/cdc-hiv-women.pdf. Accessed 23 Aug 2017.
10. American Civil Liberties Union (ACLU). Facts about the over-incarceration of
women in the United States. https://www.aclu.org/other/facts-about-over-
incarceration-women-united-states. Accessed 22 Aug 2017.
11. The Sentencing Project. Women in the criminal justice system: briefing sheets.
May 1, 2007. https://www.sentencingproject.org/publications/women-in-the-
criminal-justice-system-briefing-sheets/. Accessed 23 Aug 2017.
12. The Sentencing Project. Incarcerated women and girls. http://www.
sentencingproject.org/wp-content/uploads/2016/02/Incarcerated-Women-
and-Girls.pdf. Accessed 23 Aug 2017.
13. Minton TD, Golinelli D. Jail inmates at midyear 2013 - statistical tables.
Washington, DC: U.S. Department of Justice, Office of Justice Programs,
Bureau of Justice Statistics; 2014. https://www.bjs.gov/index.cfm?ty=
pbdetail&iid=4988. Accessed 23 Aug 2017.
14. Koch DW, Lee J, Lee K. Coloring the war on drugs: arrest disparities in black,
brown, and white. Race Soc Probl. 2016;8(4):313–25.
15. Justice Center, Council of State Governments. Building trust and legitimacy
within community corrections. 2016. https://csgjusticecenter.org/
corrections/publications/building-trust-and-legitimacy-within-community-
corrections/. Accessed 23 Aug 2017.
16. Vera Institute of Justice. The potential of community corrections to improve
safety and reduce incarceration. 2013. https://www.vera.org/publications/
the-potential-of-community-corrections-to-improve-safety-and-reduce-
incarceration-configure. Accessed 8 May 2017.
17. Belenko S, et al. HIV risk behaviors, knowledge, and prevention education
among offenders under community supervision: a hidden risk group. AIDS
Educ Prev. 2004;16(4):367–85.
18. Adimora AA, Schoenbach VJ. Social context, sexual networks, and racial
disparities in rates of sexually transmitted infections. J Infect Dis. 2005;
191(Suppl 1):115–22.
19. Adimora AA, Schoenbach VJ, Doherty IA. HIV and African Americans in the
southern United States: sexual networks and social context. Sex Transm Dis.
2006;33(Suppl 7):39–45.
20. Adimora AA, Schoenbach VJ, Floris-Moore MA. Ending the epidemic of
heterosexual HIV transmission among African Americans. Am J Prev Med.
2009;37(5):468–71.
21. Gilbert L, et al. Efficacy of a computerized intervention on HIV and intimate
partner violence among substance-using women in community corrections:
a randomized controlled trial. Am J Public Health. 2016;106(7):1278–86.
22. Beckwith CG, et al. Opportunities to diagnose, treat, and prevent HIV in
the criminal justice system. J Acquir Immune Defic Syndr. 2010;55(Suppl
1):S49–55.
23. Kramer K, Comfort M. Considerations in HIV prevention for women affected by
the criminal justice system. Womens Health Issues. 2011;21(Suppl 6):272–7.
24. Meyer JP, et al. Leveraging the U.S. criminal justice system to access women
for HIV interventions. AIDS Behav. 2017;21(12):3527–48.
25. Belenko S, Hiller M, Hamilton L. Treating substance use disorders in the
criminal justice system. Curr Psychiatry Rep. 2013;15(11):414.
26. Haley DF, et al. Multilevel challenges to engagement in HIV care after
prison release: a theory-informed qualitative study comparing prisoners’
perspectives before and after community reentry. BMC Public Health.
2014;14(1):1253.
27. Painter TM, et al. Community-based program to prevent HIV/STD infection
among heterosexual black women. MMWR Suppl. 2014;63(01):15–20.
28. Alemagno SA, et al. Brief motivational intervention to reduce HIV risk and to
increase HIV testing among offenders under community supervision. J
Correct Health Care. 2009;15(3):210–21.
29. Prendergast M, et al. A multi-site, randomized study of strengths-based case
management with substance-abusing parolees. J Exp Criminol. 2011;7(3):225–53.
30. Brown R, et al. Community-based treatment for opioid dependent
offenders: a pilot study. Am J Addict. 2013;22(5):500–2.
31. Gordon MS, et al. Rapid HIV testing for individuals on probation/parole:
outcomes of an intervention trial. AIDS Behav. 2013;17(6):2022–30.
32. Nydegger LA, et al. Effects of a one-hour intervention on condom
implementation intentions among drug users in Southern California. AIDS
Care. 2013;25(12):1586–91.
33. Lichtenstein B, Barber BW, West Alabama AIDS Outreach Partnership Group.
A partnership approach to providing on-site HIV services for probationers
and parolees: a pilot study from Alabama, USA. J Int AIDS Soc. 2016;19(4
Suppl 3):20868.
34. DiClemente RJ, et al. Efficacy of an HIV prevention intervention for African
American adolescent girls: a randomized controlled trial. JAMA. 2004;292(2):
171–9.
35. Crepaz N, et al. The efficacy of HIV/STI behavioral interventions for African
American females in the United States: a meta-analysis. Am J Public Health.
2009;99(11):2069–78.
36. El-Bassel N, et al. National Institute of Mental Health Multisite Eban HIV/STD
Prevention Intervention for African American HIV serodiscordant couples: a
cluster randomized trial. Arch Intern Med. 2010;170(17):1594–601.
37. Adimora AA, Schoenbach VJ. Contextual factors and the black-white
disparity in heterosexual HIV transmission. Epidemiology. 2002;13(6):707–12.
38. El-Bassel N, et al. Correlates of crack abuse among drug-using incarcerated
women: psychological trauma, social support, and coping behavior. Am J
Drug Alcohol Abuse. 1996;22(1):41–56.
39. Epperson MW, et al. Fear, trust, and negotiating safety: HIV risks for black
female defendants. Affilia. 2009;24(3):257–71.
40. Weir BW, et al. Reducing HIV and partner violence risk among women with
criminal justice system involvement: a randomized controlled trial of two
Motivational Interviewing-based interventions. AIDS Behav. 2009;13(3):509–22.
41. Kalichman SC, et al. Sexual coercion, domestic violence, and negotiating
condom use among low-income African American women. J Womens
Health. 1998;7(3):371–8.
42. El-Bassel N, et al. Correlates of partner violence among female street-based
sex workers: substance abuse, history of childhood abuse, and HIV risks.
AIDS Patient Care STDS. 2001;15(1):41–51.
43. Gielen AC, et al. HIV/AIDS and intimate partner violence: intersecting
women's health issues in the United States. Traum Viol Abuse. 2007;8(2):
178–98.
44. Mittal M, Senn TE, Carey MP. Intimate partner violence and condom use
among women: does the Information–Motivation–Behavioral Skills Model
explain sexual risk behavior? AIDS Behav. 2012;16(4):1011–9.
45. Gilbert L, et al. Targeting the SAVA (substance abuse, violence and AIDS)
syndemic among women and girls: a global review of epidemiology and
integrated interventions. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):
118–27.
46. Curran GM, et al. Effectiveness-implementation hybrid designs: combining
elements of clinical effectiveness and implementation research to enhance
public health impact. Med Care. 2012;50(3):217–26.
47. Metsch LR, et al. Implementing rapid HIV testing with or without risk-
reduction counseling in drug treatment centers: results of a randomized
trial. Am J Public Health. 2012;102(6):1160–7.
48. Metsch LR, et al. Effect of risk-reduction counseling with rapid HIV testing
on risk of acquiring sexually transmitted infections: the AWARE randomized
clinical trial. JAMA. 2013;310(16):1701–10.
49. Bandura A. Self-efficacy: toward a unifying theory of behavioral change.
Psychol Rev. 1977;84(2):191–215.
50. Bandura A. Social cognitive theory of self-regulation. Organ Behav Hum
Decis Process. 1991;50(2):248–87.
51. Peled E, et al. Choice and empowerment for battered women who stay:
toward a constructivist model. Soc Work. 2000;45(1):9–25.
52. Damschroder LJ, et al. Fostering implementation of health services research
findings into practice: a consolidated framework for advancing
implementation science. Implement Sci. 2009;4(1):50.
53. El-Bassel N, et al. Preventing HIV/AIDS in drug-abusing incarcerated women
through skills building and social support enhancement: preliminary
outcomes. Soc Work Res. 1995;19(3):131–41.
54. Schilling RF, et al. Correlates of drug use, sexual behavior, and attitudes
toward safer sex among African-American and Hispanic women in
methadone maintenance. J Drug Issues. 1991;21(4):685–98.
55. Bandura A. Perceived Self-Efficacy in Cognitive Development and
Functioning, Educational Psychologist. 1993;28(2):117–48. https://doi.org/10.
1207/s15326985ep2802_3.
56. Daveson B, et al. Translating care into outcomes: a grounded theory study
using the Consolidated Framework for Implementation Research (CFIR)
[abstract PO51]. Palliat Med. 2016;30(6):NP269–70.
57. Kirk MA, et al. A systematic review of the use of the Consolidated
Framework for Implementation Research. Implement Sci. 2016;11(1):72.
58. Liang S, et al. Integrating evidence-based practices for increasing
cancer screenings in safety net health systems: a multiple case study
using the Consolidated Framework for Implementation Research.
Implement Sci. 2016;11:109.
Johnson et al. Trials  (2018) 19:486 Page 18 of 19
59. Northridge ME, et al. Third places for health promotion with older adults:
using the Consolidated Framework for Implementation Research to
enhance program implementation and evaluation. J Urban Health. 2016;
93(5):851–70.
60. Birken SA, et al. Combined use of the Consolidated Framework for
Implementation Research (CFIR) and the Theoretical Domains Framework
(TDF): a systematic review. Implement Sci. 2017;12:2.
61. Klafke N, et al. How the Consolidated Framework for Implementation
Research can strengthen findings and improve translation of research into
practice: a case study. Oncol Nurs Forum. 2017;44(5):E223–31.
62. VanDevanter N, et al. Application of the Consolidated Framework for
Implementation Research to assess factors that may influence
implementation of tobacco use treatment guidelines in the Viet Nam public
health care delivery system. Implement Sci. 2017;12:27.
63. Lewin K. Frontiers in group dynamics: II. Channels of group life; social
planning and action research. Hum Relat. 1947;1(2):143–53.
64. Khan MR, et al. The promise of multimedia technology for STI/HIV
prevention: frameworks for understanding improved facilitator delivery and
participant learning. AIDS Behav. 2012;16(7):1949–60.
65. Rollnick S, Miller WR. What is Motivational Interviewing? Behav Cogn
Psychother. 1995;23(4):325–34.
66. Dowding D. Best Practices for Mixed Methods Research in the Health
Sciences [book review]. Qual Soc Work. 2013;12(4):541–5.
67. Russell LB. The science of making better decisions about health: cost-
effectiveness and cost-benefit analysis. Presented at the Population Health
Workshop sponsored by the Office of Behavioral and Social Science
Research, National Institutes of Health, March 26–27, 2014. http://www.sas.
rutgers.edu/virtual/snde/wp/2014-06.pdf. Accessed 30 Aug 2017.
68. Musgrove P, Fox-Rushby J. Cost-effectiveness analysis for priority setting. In
Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha
P, Mills A, Musgrove P, editors. Disease control priorities in developing
countries. 2nd ed. Washington, DC: International Bank for Reconstruction
and Development/The World Bank Group and New York: Oxford University
Press; 2006.
69. Pinkerton SD, et al. Toward a standard sexual behavior data set for HIV
prevention evaluation. Am J Health Behav. 1998;22(4):259–66.
70. Cohen DA, Wu SY, Farley TA. Comparing the cost-effectiveness of HIV
prevention interventions. J Acquir Immune Defic Syndr. 2004;37(3):1404–14.
71. Goodman LA, Corcoran C, Turner K, Yuan N, & Green BL. Assessing
traumatic event exposure: General issues and preliminary findings for the
stressful life events screening questionnaire. J Trauma Stress. 1998;11(3):
521–542. https://doi.org/10.1023/A:1024456713321.
72. Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The PTSD Checklist
(PCL): Reliability, validity and diagnostic utility. Paper presented at the
Annual Meeting of the International Society for Traumatic Stress Studies;
San Antonio. 1993;1993.
73. Kraanen FL, Vedel E, Scholing A, & Emmelkamp PM. The comparative
effectiveness of Integrated treatment for Substance abuse and Partner
violence (IStoP) and substance abuse treatment alone: a randomized
controlled trial. BMC Psychiatry. 2013;13:189. https://doi.org/10.1186/1471-
244X-13-189.
74. Strauss MA, Hamby SL, Boney-McCoy S & Sugarman MA. The Revised
Conflict Tactics Scales (CTS2). Development and Preliminary Psychometric
Data. J Fam Issues. 1996;17(3):283–316. https://doi.org/10.1177/
019251396017003001
Johnson et al. Trials  (2018) 19:486 Page 19 of 19
